NEW
YORK, May 24, 2022 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) and its board of
directors concerning the proposed acquisition of the company by
Innoviva, Inc. (NASDAQ: INVA). Stockholders will receive
$2.20 for each share of Entasis
Therapeutics Holdings stock that they hold. Innoviva currently owns
approximately 60% of Entasis Therapeutics Holdings common stock.
The transaction is valued at approximately $113 million and is expected to close in the
third quarter of 2022.
If you are a stockholder of Entasis Therapeutics Holdings Inc.
and are interested in obtaining additional information regarding
this investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/ettx/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-entasis-therapeutics-holdings-inc-301554441.html
SOURCE Rowley Law PLLC
